Nanavaty Maulik

Nanavaty Maulik is listed in filings as Director at Rani Therapeutics Holdings, Inc.. This profile follows SEC Form 4 activity through May 30, 2025, including 4 public disclosures. Recent filings connect the profile to Rani Therapeutics Holdings, Inc. (RANI). The current snapshot covers public activity from Dec 17, 2024 to May 30, 2025. Reported amounts are shown as $31.0K to $145.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.